Sometimes the best news is finding out someone wants to buy your company. That's the story for Bark Inc. (BARK) this morning, as shares of the pet products company rocketed higher in premarket trading after a 13D filing revealed that Great Dane delivered a non-binding letter to the board expressing interest in acquiring the company.

Bark shares climbed 19.9% to $0.74 in the premarket session, giving investors something to wag their tails about.

But Bark wasn't the only stock making waves before the opening bell. Here's a look at the other notable movers in premarket trading.

The Gainers

Signing Day Sports Inc. (SGN) topped the leaderboard with a 43.7% surge to $0.71 in premarket trading, though no specific catalyst was immediately apparent for the move.

Ping An Biomedical Co Ltd (PASW) bounced back sharply, rising 34.3% to $0.27 in premarket trading. This comes after the stock took a brutal 68% hit on Friday, so today's move looks like a recovery attempt after getting absolutely hammered.

Abivax SA (ABVX) climbed 23.6% to $141.35 in premarket trading. The catalyst here was clearer: Morgan Stanley analyst Judah Frommer maintained an Overweight rating on Friday and raised his price target from $101 to $145. That's the kind of upgrade that gets attention.

Cellectar Biosciences Inc. (CLRB) gained 18.4% to $3.65 in premarket trading, recovering some ground after falling 7% on Friday.

China SXT Pharmaceuticals Inc. (SXTC) surged 17.5% to $0.18 in premarket trading, attempting a comeback after an 88% plunge on Friday. The company announced a $10 million registered direct offering, which typically pressures stock prices, but in this case seems to have provided some stability after the previous day's collapse.

Kingsoft Cloud Holdings Ltd (KC) gained 13.8% to $12.55 in premarket trading, though no specific news appeared to drive the move.

Critical Metals Corp (CRML) rose 12.3% to $16.82 in premarket trading, continuing momentum after jumping 11% on Friday.

Rich Sparkle Holdings Ltd (ANPA) gained 11.7% to $97.00 in premarket trading. The stock already had a monster day Friday, soaring 259% after the company announced it signed a $39 million offering of 3 million shares at $13 per share. Today's move suggests the momentum hasn't faded yet.

3 E Network Technology Group Ltd (MASK) rose 10.3% to $0.41 in premarket trading after announcing a subsequent closing of a $2 million convertible promissory note offering.

The Losers

Not everyone was having a good morning, of course.

Lexaria Bioscience Corp (LEXX) fell 12.9% to $0.65 in premarket trading, giving back some of Friday's 7% gain.

Plus Therapeutics Inc (PSTV) dropped 11.8% to $0.49 in premarket trading as the company announced an offering of 22,321,429 pre-funded units at $0.56 per unit. Dilution concerns tend to weigh on small-cap stocks, and that appears to be the case here.

RenovoRx Inc (RNXT) fell 11.3% to $0.99 in premarket trading after declining around 3% on Friday, extending its recent slide.

Synchrony Financial (SYF) dipped 9.5% to $78.61 in premarket trading, leading a broader selloff in financial services stocks.

Eastern International Ltd (ELOG) shares dipped 9.1% to $1.41 in premarket trading, pulling back after a 30% jump on Friday.

Stoke Therapeutics Inc (STOK) declined 8.7% to $30.00 in premarket trading. The company announced updates to timelines for the completion of enrollment and a Phase 3 data readout from the EMPEROR study of zorevunersen for the treatment of Dravet syndrome. Timeline delays in clinical trials rarely go over well with investors.

Capital One Financial Corp (COF) fell 8.4% to $228.35 in premarket trading, joining other financial services names in the red.

Bread Financial Holdings Inc (BFH) tumbled 8.3% to $73.72 in premarket trading, part of what appeared to be sector-wide weakness in consumer finance.

OSR Holdings Inc (OSRH) fell 8% to $0.61 in premarket trading after gaining 6% on Friday, another example of giving back recent gains.

Himalaya Shipping Ltd (HSHP) dipped 5.7% to $8.72 in premarket trading, rounding out the list of notable decliners.

The premarket session painted a picture of significant volatility across small-cap names, with offerings and clinical trial updates driving sharp moves in both directions. Meanwhile, the weakness in financial services stocks suggested broader sector concerns that could carry into the regular trading session.